文献速递关节外科

无菌性翻修全髋关节置换术中未预料到的术中培养阳性:患病率、处理与无感染生存率

Unsuspected Positive Intra-Operative Cultures in Aseptic Revision Hip Arthroplasty: Prevalence, Management, and Infection-Free Survivorship.
PubMed 文献 · J Arthroplasty · 2024-10-30

该研究回顾性分析2013年1月至2023年10月单中心604例无菌性翻修全髋关节置换术,按术中培养结果分组。

要点

  • 单一新微生物阳性组与无菌培养组5年无感染生存率无差异(P=0.40)。
  • ≥2次不同或相同微生物阳性及既往假体周围感染史者无感染生存率显著更差。

核心结论

  • 单一新微生物阳性的无菌性翻修全髋关节置换术患者5年无感染生存率与无菌培养者相似。
  • ≥2次培养阳性及既往假体周围感染史均为无菌性翻修全髋关节置换术后因感染再翻修的显著危险因素。

研究设计与样本

  • 单中心三级医院机构数据库回顾性分析,纳入2013年1月至2023年10月无菌性翻修全髋关节置换术病例。
  • 根据术前可用感染检查结果计算肌肉骨骼感染学会评分,排除符合假体周围感染标准、接受抗生素间隔物或随访不足1年者。
  • 共纳入604例无菌性翻修全髋关节置换术,按术中培养结果分为无菌培养、单一新微生物阳性、单一与既往假体周围感染相同微生物阳性、≥2次不同微生物阳性、≥2次相同微生物阳性五组进行比较。

主要发现

  • 604例中,≥2次不同微生物阳性占0.8%(5/604),≥2次相同微生物阳性占1.5%(9/604),单一新微生物阳性占9.8%(59/604),单一与既往假体周围感染相同微生物阳性占0.2%(1/604),无菌培养占87.7%(530/604)。
  • 单一新微生物阳性组与无菌培养组5年无感染生存率比较无差异(P=0.40)。
  • ≥2次不同微生物阳性组(P<0.001)、≥2次相同微生物阳性组(P=0.001)及单一与既往假体周围感染相同微生物阳性组(P<0.001)的无感染生存率均显著差于无菌培养组。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to describe the management and outcomes of aseptic revision total hip arthroplasty (arTHA) with unsuspected intraoperative positive cultures (UPCs) compared to those with sterile cultures. METHODS: A single tertiary center's institutional database was retrospectively reviewed for arTHA from January 2013 to October 2023. Preoperative Musculoskeletal Infection Society scores were assigned to patients based on available infectious workup, and those who met the criteria for periprosthetic joint infection (PJI), received antibiotic spacers, or had less than 1-year follow-up were excluded. Patients were grouped and compared according to intraoperative culture results as follows: sterile cultures, one unexpected positive culture with a new organism, one UPC with the same organism as prior PJI, ≥ two UPCs with different organisms, and ≥ 2 UPCs with the same organism. RESULTS: There was a total of 604 arTHAs included in this study, of which 0.8% [5 of 604] had ≥ two UPCs with different organisms, 1.5% [9 of 604] had ≥ two UPCs with the same organism, 9.8% [59 of 604] had one UPC with a new organism, 0.2% [one of 604] had one UPC with an organism from prior PJI, and 87.7% [530 of 604] of patients had sterile cultures. When comparing 5-year infection-free survival between patients who had one UPC with a new organism and sterile cultures, there was no difference (P = 0.40); however, patients who had ≥ two UPCs with different organisms (P < 0.001), patients who had ≥ two UPCs with the same organism (P = 0.001), and patients who had one UPC of an organism from prior PJI (P < 0.001) had statistically worse infection-free survival compared to patients with sterile cultures. CONCLUSIONS: Infection-free survival at five years was similar between patients who had one UPC with a new organism and those who had sterile cultures; however, ≥ two UPCs and a history of PJI are both significant risk factors for rerevision for infection after arTHA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Leal J, Wu CJ, Seyler TM, et al. Unsuspected Positive Intra-Operative Cultures in Aseptic Revision Hip Arthroplasty: Prevalence, Management, and Infection-Free Survivorship. J Arthroplasty. 2024. PMID: 39481617. doi:10.1016/j.arth.2024.10.102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。